Researchers at UCLA have developed a pathway for producing variants of butanol and C5-based alcohols using E.Coli.
This strategy leverages the E. coli host’s highly active amino acid biosynthetic pathway by shifting part of it to alcohol production. In particular, the research team achieved high-yield, high-specificity production of isobutanol from glucose.
“These alcohols are typically trace byproducts in fermentation,” Liao said. “To modify an organism to produce these compounds usually results in toxicity in the cell. We bypassed this difficulty by leveraging the native metabolic networks in E. coli but altered its intracellular chemistry using genetic engineering to produce these alcohols.”
Or in other words, this isn’t a fermentation, this is using the internal biochemistry, aided through genetic alterations, to convert glucose into 4 and 5-carbon alcohols.
E.Coli is widely used in academia and industry for doing recombinant DNA-based processes. For example, Genentech uses E.Coli to manufacture several of its products and is an expression platform for much of its research efforts. It’s a well understood bacterium so it’s no surprise that this type of research has proved successful.
In one of GreenCarCongress’s comments, a user noted that DuPont had patented this type of a process last year (2007). I looked this up and found the cited patent application.
